tailieunhanh - Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: An openlabel, phase I trial with an extensive biomarker program

To date, the cornerstone of treatment in patients with advanced or metastatic cholangiocarcinoma (CCA) is systemic chemotherapy based on a combination of gemcitabine and a platinum derivative. | Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine cisplatin in chemotherapy-naive patients with advanced biliary tract cancer An openlabel phase I trial with an extensive biomarker program

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN